Another study (Mansharamani et al., 2000) indicated that in immunosuppressed persons without HIV infection, CD4 + counts may be a useful clinical marker to identify specific individuals at particularly high clinical risk for PJP. The gene discussed is CD4; the disease is pneumocystosis.